back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-10-07 13:37 Tx date 2024-10-07 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,184.82
-694 vol $6.03 each |
7,776 | |
| Filed 2024-09-09 13:08 Tx date 2024-09-09 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,164
-694 vol $6.00 each |
8,470 | |
| Filed 2024-09-03 17:11 Tx date 2024-09-03 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-12,554.46
-2,082 vol $6.03 each |
9,164 | |
| Filed 2024-05-06 12:45 Tx date 2024-05-06 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,823.30
-694 vol $6.95 each |
11,246 | |
| Filed 2024-04-24 18:53 Tx date 2024-04-24 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$18,375
+3,750 vol $4.90 each |
43,240 | |
| Filed 2024-04-24 18:52 Tx date 2024-04-24 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-18,375
-3,750 vol $4.90 each |
203,250 | |
| Filed 2024-04-05 16:51 Tx date 2024-04-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-5,509.666
-694 vol $7.94 each |
11,940 | |
| Filed 2024-03-27 17:12 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Lauren, Merendino
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$225,999
+25,000 vol $9.04 each |
75,000 | |
| Filed 2024-03-27 17:06 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Kantoff, Philip Wayne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
100,000 | |
| Filed 2024-03-27 17:05 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
139,000 | |
| Filed 2024-03-27 17:03 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
139,000 | |
| Filed 2024-03-27 17:02 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Zweifach, Sanford
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
139,000 | |
| Filed 2024-03-27 17:00 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
156,000 | |
| Filed 2024-03-27 16:58 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
113,793 | |
| Filed 2024-03-27 16:57 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
156,000 | |
| Filed 2024-03-27 16:24 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$632,799
+70,000 vol $9.04 each |
207,000 | |
| Filed 2024-03-27 16:21 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,807,999
+200,000 vol $9.04 each |
830,000 | |
| Filed 2024-03-27 16:18 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$994,399
+110,000 vol $9.04 each |
835,000 | |
| Filed 2024-03-27 16:16 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$994,399
+110,000 vol $9.04 each |
1,722,500 | |
| Filed 2024-03-27 16:12 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,163,999
+350,000 vol $9.04 each |
2,618,896 |